12:00 AM
 | 
Jan 26, 2004
 |  BioCentury  |  Finance

One miss

One miss

Company 4Q EPS est 4Q EPS actual Outcome Growth from 4Q02 1/23 cls Wk chg %chg Mkt cap chg ($M) 1/23 mkt cap ($M)
Amgen (AMGN) $0.48 $0.50 Beat by $0.02 43% $63.93 $0.43 1% $552 $82,022
4Q03 EPS was $0.46, which included an $87M ($0.04 post-tax) expense related to an upfront payment to Biovitrum. 4Q03 sales...

Read the full 403 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >